moxonidine has been researched along with ng-nitroarginine methyl ester in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombari, E; Menani, JV; Moreira, TS; Sato, MA; Takakura, AC | 2 |
| Aguayo-Morales, H; Centurión, D; Cobos-Puc, LE; González-Zavala, MA; Silva-Belmares, Y | 1 |
3 other study(ies) available for moxonidine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension.
Topics: Animals; Bradycardia; Brain Stem; Brazil; Drug Combinations; Echocardiography, Doppler, Pulsed; Fourth Ventricle; Hypotension; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Male; Microinjections; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Vascular Resistance; Vasodilation | 2004 |
Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide.
Topics: Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradycardia; Drug Interactions; Endothelium-Dependent Relaxing Factors; Excitatory Amino Acid Antagonists; Heart Rate; Hypertension; Hypotension; Imidazoles; Kynurenic Acid; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 2006 |
α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Gene Expression Regulation, Enzymologic; Heart; Hemodynamics; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Stellate Ganglion; Sympathetic Nervous System; Tachycardia | 2016 |